---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-069380"
form_type: "8-K"
ticker: "OM"
cik: "0001484612"
company_name: "Outset Medical, Inc."
filed_at: "2023-12-11T23:59:59+00:00"
generated_at: "2026-06-07T14:49:00.172131+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Outset Medical borrows $33.5M under amended SLR term loan; total debt ~$133.5M

## Summary
- On Dec 11, 2023, Outset amended its SLR term loan, restructuring the $100M Term B into two tranches: B-1 ($33.5M) and B-2 ($66.5M).
- Outset borrowed the full Term B-1 tranche on the amendment date, increasing outstanding principal to ~$133.5M.
- The Term A loan of $100M was drawn in Nov 2022; Term B-2 remains available subject to conditions.
- No other material terms of the SLR term loan were changed by the amendment.

## SEC filing metadata
- accession: 0000950170-23-069380
- form_type: 8-K
- ticker: OM
- cik: 0001484612
- company_name: Outset Medical, Inc.
- filed_at: 2023-12-11T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1484612/000095017023069380/0000950170-23-069380-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1484612/000095017023069380/om-20231211.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-069380
- JSON: https://secwatch.observer/filing/0000950170-23-069380.json
- Plain text: https://secwatch.observer/filing/0000950170-23-069380.txt

## Key facts
- Debt Financings
  Outset Medical, Inc. incurred term loan of $100.0 million Term B Loans will be available in two tranches consisting of (i) Term B-1 Loans in the aggregate amount o with SLR Investment Corp., as collateral agent, the lenders from time to time party thereto.
  - Instrument: term loan
  - Principal: $100.0 million Term B Loans will be available in two tranches consisting of (i) Term B-1 Loans in the aggregate amount o
  - Counterparty: SLR Investment Corp., as collateral agent, the lenders from time to time party thereto
  - Event: incurrence
  source text: The SLR Term Loan Amendment provides that the $100.0 million Term B Loans will be available in two tranches consisting of (i) Term B-1 Loans in the aggregate amount of approximately $33.5 million and (ii) Term B-2 Loans in the aggregate amount of approximately $66.5 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017023069380/0000950170-23-069380-index.htm
- Debt Financings
  Outset Medical, Inc. incurred term loan of Term B-1 Loans in the aggregate amount of approximately $33.5 million with SLR Investment Corp., as collateral agent, the lenders from time to time party thereto.
  - Instrument: term loan
  - Principal: Term B-1 Loans in the aggregate amount of approximately $33.5 million
  - Counterparty: SLR Investment Corp., as collateral agent, the lenders from time to time party thereto
  - Event: incurrence
  source text: the Company borrowed and received the entire Term B-1 Loans from the Term Loan Lenders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017023069380/0000950170-23-069380-index.htm
- Material Agreements
  Outset Medical, Inc. amended First Amendment to Loan and Security Agreement with SLR Investment Corp. valued at Amendment provides for $100.0 million Term B Loans in two tranches (B-1 ~$33.5M, B-2 ~$66.5M); borro (effective 2023-12-11).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: SLR Investment Corp.
  - Value: Amendment provides for $100.0 million Term B Loans in two tranches (B-1 ~$33.5M, B-2 ~$66.5M); borro
  - Effective: 2023-12-11
  source text: On December 11, 2023 (the Amendment Effective Date), the Company amended the SLR Term Loan Facility pursuant to a First Amendment to Loan and Security Agreement (the SLR Term Loan Amendment) among the Collateral Agent, the Term Loan Lenders and the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1484612/000095017023069380/0000950170-23-069380-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.